The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential ...

Moderna's cost-cutting drives better-than-expected results Combination COVID and flu shot approval not expected until 2026 Tariffs have minimal impact on Moderna's U.S.-manufactured drugs May 1 ...

Moderna initiated the dosing for its innovative mRNA-4106 cancer therapy in a Phase 1 trial, signaling ongoing advancements in their oncology pipeline. However, the company's stock experienced a 3 ...

Covid vaccine manufacturer Moderna has completed a new site in the UK, which it says will help prepare the the country against future pandemics. The Moderna Innovation and Technology Centre (MITC ...

The requirement for placebo-controlled trials isn’t expected to affect the rollout this fall for older adults and other ...

Reputable Apple leaker Sonny Dickson shared a first look at a prototype pair of Powerbeats Pro 2 in a transparent colorway. Apple initially debuted the Powerbeats Pro 2 back in February ...

(Reuters) -Moderna on Thursday pushed back the time frame for likely approval of a combination vaccine meant to protect against both COVID-19 and influenza, but said exchanges with U.S. drug ...

FILE – A vial of Moderna COVID-19 vaccine rests on a table at an inoculation station in Jackson, Miss., on July 19, 2022. (AP Photo/Rogelio V. Solis, File) A combination shot for flu and Covid ...

By Patrick Wingrove (Reuters) -Moderna on Thursday reported first-quarter profit and sales that beat Wall Street estimates, helped by the company's cost-cutting efforts following waning post ...

Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the results of a phase 3 clinical trial published Wednesday in the Journal of ...